亚星化学：正在推进重大资产重组事项

Core Viewpoint - The company announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices over two consecutive trading days [1] Group 1: Company Operations - The company's daily operations are reported to be normal, with no significant changes in the market environment or industry policies [1] - The company is advancing a major asset restructuring plan to acquire 100% of Tianyi Chemical through a combination of issuing shares and cash payments, which has been approved by the board of directors and is pending shareholder approval [1] Group 2: Disclosure and Verification - The company conducted a self-examination and verified with its controlling shareholder, confirming that there are no undisclosed significant matters affecting the abnormal stock price fluctuation, aside from information already disclosed in designated media [1]